Medpage Today on MSN11d
Gene Therapy Shows Promise in Rare Eye Disease That Causes Early Blindness
A subretinal gene therapy was well tolerated 1 year after treatment, with no drug-related serious adverse events, in a small ...
BioSpace6d
4DMT’S Gene Therapy for AMD Clears Phase II, Heads to Late-Stage Studies
D Molecular Therapeutics reported its experimental gene therapy demonstrated a nearly 90% reduction in the need for ...
Medscape15d
Gene Therapy Shown to Improve Vision in Congenital Blindness
In an early phase trial, gene therapy showed an ability to restore function to rods and cones as well as functional vision ...
Nature10mon
Worsening of an existing hemispheric retinal vein occlusion following further hypotony procedure
Dev S, Herndon L, Shields MB . Retinal vein occlusion after trabeculectomy with mitomycin C. Am J Ophthalmol 1996;122:574–5.
Medscape10y
Nd:YAG Laser Goniopuncture
an iridectomy and late conversion to filtering surgery may become necessary Hypotony Uncommon occurrence; can be accompanied by a shallow anterior chamber and/or choroidal effusion/detachment ...
4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day
D-150 demonstrated robust and durable clinical activity across all wet age-related macular degeneration (wet AMD) patient populations based on ...